cardiovascular-agents and Schistosomiasis

cardiovascular-agents has been researched along with Schistosomiasis* in 1 studies

Other Studies

1 other study(ies) available for cardiovascular-agents and Schistosomiasis

ArticleYear
Active schistosomiasis, severe hypereosinophilia and rapid progression of chronic endomyocardial fibrosis.
    Cardiovascular journal of Africa, 2016, Oct-23, Volume: 27, Issue:5

    Endomyocardial fibrosis (EMF) is a neglected restrictive cardiomyopathy of unknown aetiology and unclear natural history, which causes premature deaths in endemic areas. We present the case of a 13-year-old boy from a highly endemic area, presenting with concurrent signs of chronic EMF and severe hypereosinophilia associated with active schistosomal cystitis. We discuss the possible role of this parasitic infection in determining the progression of EMF in endemic areas for both conditions.

    Topics: Adolescent; Antiplatyhelmintic Agents; Autopsy; Biopsy; Cardiovascular Agents; Chronic Disease; Endomyocardial Fibrosis; Fatal Outcome; Humans; Hypereosinophilic Syndrome; Male; Myocardium; Schistosomiasis; Severity of Illness Index; Treatment Outcome

2016